NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)

The National Library of Medicine (NLM) is issuing a grant program (G13) to support the creation of book‑length manuscripts and other scholarly works that synthesize, review, and contextualize biomedical and public‑health knowledge for U.S. health professionals, scientists, and related audiences. Up to four awards will be made, each ranging from $10,000 to $80,000, with a total estimated funding pool of $320,000. The program explicitly excludes clinical trial (G13) activities and focuses on integrative scholarship such as critical reviews, analytical syntheses, and other high‑impact publications. Eligible applicants include a broad mix of governmental entities, non‑profits, tribal organizations, for‑profit firms, and educational institutions. Applications are expected to be submitted by 25 May 2027, with awards anticipated in April 2028 and project start dates the same month. • Supports preparation of book‑length manuscripts and other scholarly products in biomedicine and health. • Funding: $10‑80 k per award; total $320 k across up to four awards. • Broad eligibility – state, local, tribal, nonprofit, for‑profit, and foreign entities may apply. • No clinical‑trial (G13) work allowed; focus is on integrative review and synthesis. • Application deadline: 25 May 2027; award decision: 1 April 2028; project start: 1 April 2028. • Primary contact: NLM Extramural Programs (email [email protected]).